VKTX
Viking Therapeutics, Inc.
Company overview
- Market capitalization
- $3.85B
- Employees
- 59
- Latest publication
- 2026-09-29
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 150,150,000USD | 153,459,000USD | 89,953,000USD | 60,153,000USD | 41,391,000USD | 30,987,000USD | 22,785,000USD | 23,769,000USD |
| Selling General Administrative | 13,975,000USD | 11,279,000USD | 8,608,000USD | 14,421,000USD | 14,078,000USD | 15,251,000USD | 13,771,000USD | 10,285,000USD |
| Total Operating Expenses | 164,125,000USD | 164,738,000USD | 98,561,000USD | 74,574,000USD | 55,469,000USD | 46,238,000USD | 36,556,000USD | 34,054,000USD |
| Operating Income | -164,125,000USD | -164,738,000USD | -98,561,000USD | -74,574,000USD | -55,469,000USD | -46,238,000USD | -36,556,000USD | -34,054,000USD |
| Interest Income | 5,800,000USD | 7,035,000USD | 7,772,000USD | 9,033,000USD | 9,864,000USD | 10,844,000USD | 11,531,000USD | 11,820,000USD |
| Net Interest Income | 5,800,000USD | 7,035,000USD | 7,764,000USD | 9,009,000USD | 9,840,000USD | 10,820,000USD | 11,507,000USD | 11,802,000USD |
| Income Before Tax | -158,325,000USD | -157,662,000USD | -90,787,000USD | -65,561,000USD | -45,629,000USD | -35,417,000USD | -24,940,000USD | -22,250,000USD |
| Net Income | -158,325,000USD | -157,662,000USD | -90,787,000USD | -65,561,000USD | -45,629,000USD | -35,417,000USD | -24,940,000USD | -22,250,000USD |
| Net Income From Continuing Ops | -158,325,000USD | -157,662,000USD | -90,787,000USD | -65,561,000USD | -45,629,000USD | -35,417,000USD | -24,940,000USD | -22,250,000USD |
| Ebitda | -158,325,000USD | -157,568,000USD | -90,665,000USD | -65,425,000USD | -45,494,000USD | -35,283,000USD | -24,829,000USD | -22,157,000USD |
| Reconciled Depreciation | 85,000USD | 94,000USD | 114,000USD | 112,000USD | 111,000USD | 110,000USD | 87,000USD | 75,000USD |
| Total Other Income Expense Net | 5,800,000USD | 7,076,000USD | 7,774,000USD | 9,012,999USD | 9,840,000USD | 10,821,000USD | 11,616,000USD | 11,804,000USD |
| Cost Of Revenue | — | 94,000USD | 114,000USD | 112,000USD | — | 110,000USD | 87,000USD | 75,000USD |
| Gross Profit | — | -94,000USD | -114,000USD | -112,000USD | — | -110,000USD | -87,000USD | -75,000USD |
| Ebit | — | -157,662,000USD | -90,779,000USD | -65,537,000USD | -45,605,000USD | -35,393,000USD | -24,916,000USD | -22,232,000USD |
| Depreciation And Amortization | — | 94,000USD | 114,000USD | 112,000USD | 111,000USD | 110,000USD | 87,000USD | 75,000USD |
| Interest Expense | — | — | 8,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 18,000USD |
| Income Tax Expense | — | — | — | — | — | — | -87,000USD | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 75,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 10,701USD | 0USD | 0USD | — | — |
| Cost Of Revenue | 431,000USD | 292,000USD | 296,000USD | 0USD | 0USD | — | — |
| Gross Profit | -431,000USD | -292,000USD | -296,000USD | 0USD | 0USD | — | — |
| Research Development | 344,955,000USD | 63,806,000USD | 44,981,000USD | 6,966,842USD | 22,223,073USD | 11,613USD | 275USD |
| Selling General Administrative | 48,387,000USD | 37,021,000USD | 10,701,000USD | 5,029,636USD | 1,244,910USD | 89,463USD | 163USD |
| Total Operating Expenses | 393,342,000USD | 100,827,000USD | 55,682,000USD | 11,996,478USD | 23,467,983USD | 101,076USD | 439USD |
| Operating Income | -393,342,000USD | -100,827,000USD | -55,682,000USD | -11,996,478USD | -23,467,983USD | -101,076USD | -439USD |
| Interest Income | 33,704,000USD | 11,046,000USD | 703,000USD | 982,180USD | — | — | — |
| Interest Expense | 56,000USD | 88,000USD | 18,000USD | 1,018,502USD | 628,676USD | 24,549USD | — |
| Net Interest Income | 33,648,000USD | 10,976,000USD | 685,000USD | — | — | — | — |
| Income Before Tax | -359,639,000USD | -85,895,000USD | -54,990,000USD | -23,403,988USD | -21,884,183USD | -146,247USD | -444USD |
| Net Income | -359,639,000USD | -85,895,000USD | -54,990,000USD | -23,403,988USD | -21,884,183USD | -146,247USD | -444USD |
| Net Income From Continuing Ops | -359,639,000USD | -80,849,000USD | -54,990,000USD | -23,403,988USD | -21,884,183USD | — | — |
| Ebit | -359,583,000USD | -100,827,000USD | -54,972,000USD | -22,385,486USD | -23,467,983USD | -101,076USD | -110,080USD |
| Ebitda | -359,152,000USD | -100,827,000USD | -54,676,000USD | -21,360,085USD | -21,255,507USD | -121,698USD | -109,641USD |
| Depreciation And Amortization | 431,000USD | 292,000USD | 296,000USD | 1,025,401USD | 2,212,476USD | -20,622USD | 439USD |
| Reconciled Depreciation | 431,000USD | 290,000USD | 296,000USD | — | — | — | — |
| Total Other Income Expense Net | 33,703,000USD | 14,932,000USD | 692,000USD | -11,407,510USD | 1,583,800USD | -45,171USD | -110,588USD |
| Selling And Marketing Expenses | — | 292,000USD | — | — | — | — | — |
| Income Tax Expense | — | -292,000USD | -988,000USD | 982,184USD | 628,676USD | 24,549USD | -6USD |
| Non Operating Income Net Other | — | — | 692,000USD | -11,407,510USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | -54,990,000USD | -23,403,990USD | -21,884,183USD | — | — |
| Other Operating Expenses | — | — | — | — | — | 101,076USD | 439USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 608,242,000USD | 715,729,000USD | 739,415,000USD | 827,851,000USD | 866,993,000USD | 908,321,000USD | 937,888,000USD | 946,839,000USD |
| Other Current Assets | 5,245,000USD | 9,859,000USD | 24,133,000USD | 19,293,000USD | 14,165,000USD | 4,604,000USD | 6,209,000USD | 3,461,000USD |
| Total Liab | 106,325,000USD | 76,667,000USD | 26,385,000USD | 32,390,000USD | 20,075,000USD | 28,043,000USD | 26,440,000USD | 25,859,000USD |
| Total Stockholder Equity | 501,917,000USD | 639,062,000USD | 713,030,000USD | 795,461,000USD | 846,918,000USD | 880,278,000USD | 911,448,000USD | 920,980,000USD |
| Other Current Liab | 39,142,000USD | 23,279,000USD | 21,217,000USD | 26,018,000USD | 11,373,000USD | 17,111,000USD | 24,951,000USD | 13,669,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -1,005,871,000USD | -847,546,000USD | -689,884,000USD | -599,097,000USD | -533,536,000USD | -487,907,000USD | -452,490,000USD | -427,550,000USD |
| Cash | 118,116,000USD | 165,810,000USD | 100,376,000USD | 33,880,000USD | 37,940,000USD | 26,676,000USD | 50,347,000USD | 43,915,000USD |
| Cash And Short Term Investments | 602,964,000USD | 705,739,000USD | 714,570,000USD | 807,724,000USD | 851,858,000USD | 902,612,000USD | 930,440,000USD | 942,263,000USD |
| Total Current Assets | 608,209,000USD | 715,598,000USD | 738,703,000USD | 827,017,000USD | 866,023,000USD | 907,216,000USD | 936,649,000USD | 945,724,000USD |
| Total Current Liabilities | 106,325,000USD | 76,667,000USD | 26,067,000USD | 31,980,000USD | 19,573,000USD | 27,413,000USD | 25,685,000USD | 25,093,000USD |
| Net Debt | -118,116,000USD | -165,673,000USD | -99,621,000USD | -33,002,000USD | -36,940,000USD | -25,557,000USD | -49,112,000USD | -42,815,000USD |
| Short Term Investments | 484,848,000USD | 539,929,000USD | 614,194,000USD | 773,844,000USD | 813,918,000USD | 875,936,000USD | 880,093,000USD | 898,348,000USD |
| Accounts Payable | 67,183,000USD | 53,251,000USD | 4,413,000USD | 5,494,000USD | 7,702,000USD | 9,813,000USD | 254,000USD | 11,090,000USD |
| Property Plant Equipment Net | 0USD | 85,000USD | 666,000USD | 780,000USD | 892,000USD | 1,003,000USD | 1,113,000USD | 977,000USD |
| Property Plant Equipment Gross | 0USD | 85,000USD | 666,000USD | 780,000USD | 892,000USD | 1,003,000USD | 1,113,000USD | 977,000USD |
| Accumulated Other Comprehensive Income | -856,000USD | 378,000USD | 374,000USD | -166,000USD | -216,000USD | -788,000USD | 1,632,000USD | -2,272,000USD |
| Common Stock Shares Outstanding | 115,568,000shares | 114,005,000shares | 112,320,000shares | 112,134,000shares | 112,069,000shares | 111,344,000shares | 110,911,000shares | 110,390,171shares |
| Non Current Assets Total | 33,000USD | 131,000USD | 712,000USD | 834,000USD | 970,000USD | 1,105,000USD | 1,239,000USD | 1,115,000USD |
| Non Current Liabilities Total | 0USD | 0USD | 318,000USD | 410,000USD | 502,000USD | 630,000USD | 755,000USD | 766,000USD |
| Non Currrent Assets Other | 33,000USD | 46,000USD | 46,000USD | 54,000USD | 78,000USD | 102,000USD | 126,000USD | 138,000USD |
| Net Working Capital | 501,884,000USD | 638,931,000USD | 712,636,000USD | 795,037,000USD | 846,450,000USD | 879,803,000USD | 910,964,000USD | 920,631,000USD |
| Unclassified Equity | 1,508,642,000USD | 1,486,228,000USD | 1,402,538,000USD | 1,394,722,000USD | 1,380,668,000USD | 1,368,971,000USD | 1,362,304,000USD | 1,350,800,000USD |
| Short Term Debt | — | 137,000USD | 437,000USD | 468,000USD | 498,000USD | 489,000USD | 480,000USD | 334,000USD |
| Short Long Term Debt Total | — | 137,000USD | 755,000USD | 878,000USD | 1,000,000USD | 1,119,000USD | 1,235,000USD | 1,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 715,729,000USD | 908,321,000USD | 368,490,000USD | 168,529,000USD | 210,662,000USD | 256,502,000USD | 284,256,000USD | 302,312,000USD |
| Other Current Assets | 9,859,000USD | 4,604,000USD | 5,146,000USD | 11,555,000USD | 8,425,000USD | 7,717,000USD | 7,863,000USD | 278,000USD |
| Total Liab | 76,667,000USD | 28,043,000USD | 20,071,000USD | 23,207,000USD | 8,778,000USD | 12,158,000USD | 7,137,000USD | 4,562,000USD |
| Total Stockholder Equity | 639,062,000USD | 880,278,000USD | 348,419,000USD | 145,322,000USD | 201,884,000USD | 244,344,000USD | 277,119,000USD | 297,750,000USD |
| Other Current Liab | 23,279,000USD | 17,111,000USD | 11,299,000USD | 13,114,000USD | 7,305,000USD | 7,811,000USD | 4,044,000USD | 3,591,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -847,546,000USD | -487,907,000USD | -377,944,000USD | -292,049,000USD | -223,182,000USD | -168,192,000USD | -128,697,000USD | -102,918,000USD |
| Cash | 165,810,000USD | 26,676,000USD | 55,516,000USD | 36,632,000USD | 26,371,000USD | 29,117,000USD | 8,377,000USD | 24,779,000USD |
| Cash And Short Term Investments | 705,739,000USD | 902,612,000USD | 362,079,000USD | 155,485,000USD | 202,103,000USD | 248,386,000USD | 275,638,000USD | 301,520,000USD |
| Total Current Assets | 715,598,000USD | 907,216,000USD | 367,225,000USD | 167,040,000USD | 210,528,000USD | 256,103,000USD | 283,501,000USD | 302,133,000USD |
| Total Current Liabilities | 76,667,000USD | 27,413,000USD | 19,135,000USD | 21,947,000USD | 8,778,000USD | 12,129,000USD | 6,777,000USD | 4,550,000USD |
| Net Debt | -165,673,000USD | -25,557,000USD | -54,256,000USD | -35,068,000USD | -26,342,000USD | -28,758,000USD | -7,715,000USD | -24,779,000USD |
| Short Term Debt | 137,000USD | 489,000USD | 324,000USD | 304,000USD | 29,000USD | 330,000USD | 302,000USD | — |
| Short Long Term Debt Total | 137,000USD | 1,119,000USD | 1,260,000USD | 1,564,000USD | 29,000USD | 359,000USD | 662,000USD | — |
| Short Term Investments | 539,929,000USD | 875,936,000USD | 306,563,000USD | 118,853,000USD | 175,732,000USD | 219,269,000USD | 267,261,000USD | 276,741,000USD |
| Accounts Payable | 53,251,000USD | 9,813,000USD | 7,512,000USD | 8,529,000USD | 1,444,000USD | 3,988,000USD | 2,431,000USD | 959,000USD |
| Property Plant Equipment Net | 85,000USD | 1,003,000USD | 1,126,000USD | 1,418,000USD | 25,000USD | 321,000USD | 598,000USD | — |
| Property Plant Equipment Gross | 85,000USD | 1,003,000USD | 1,126,000USD | 1,418,000USD | 25,000USD | 321,000USD | 598,000USD | — |
| Accumulated Other Comprehensive Income | 378,000USD | -788,000USD | -389,000USD | -1,102,000USD | -549,000USD | -54,000USD | 12,000USD | -423,000USD |
| Common Stock Shares Outstanding | 112,667,000shares | 109,037,000shares | 94,347,000shares | 76,834,000shares | 77,197,680shares | 72,596,647shares | 71,959,093shares | 57,580,000shares |
| Non Current Assets Total | 131,000USD | 1,105,000USD | 1,265,000USD | 1,489,000USD | 134,000USD | 399,000USD | 755,000USD | 179,000USD |
| Non Current Liabilities Total | 0USD | 630,000USD | 936,000USD | 1,260,000USD | 1,473,000USD | 29,000USD | 360,000USD | 12,000USD |
| Non Currrent Assets Other | 46,000USD | 102,000USD | 139,000USD | 71,000USD | 109,000USD | 78,000USD | 157,000USD | 179,000USD |
| Net Working Capital | 638,931,000USD | 879,803,000USD | 348,090,000USD | 145,093,000USD | 201,750,000USD | 243,975,000USD | 276,724,000USD | 297,583,000USD |
| Unclassified Equity | 1,486,228,000USD | 1,368,971,000USD | 726,750,000USD | 445,266,000USD | 425,613,000USD | 412,588,000USD | 405,802,000USD | 401,089,000USD |
| Current Deferred Revenue | — | — | -11,623,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 38,000USD | 76,000USD | 48,000USD | 128,000USD | 12,000USD |
| Other Assets | — | — | — | 71,000USD | 109,000USD | 398,000USD | 157,000USD | 179,000USD |
| Treasury Stock | — | — | — | -6,795,000USD | — | — | — | — |
| Non Current Liabilities Other | — | — | — | 1,260,000USD | — | 29,000USD | 360,000USD | — |
| Net Tangible Assets | — | — | — | 145,322,000USD | 201,884,000USD | 244,344,000USD | 277,119,000USD | 297,750,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | 1,397,000USD | — | — | — |
| Other Liab | — | — | — | — | — | — | — | 12,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -158,325,000USD | -157,662,000USD | -90,787,000USD | -65,561,000USD | -45,629,000USD | -35,417,000USD | -24,940,000USD | -22,250,000USD |
| Depreciation | -1,208,000USD | 94,000USD | 114,000USD | -5,587,000USD | 111,000USD | 110,000USD | 87,000USD | 75,000USD |
| Stock Based Compensation | 10,337,000USD | 8,587,000USD | 7,336,000USD | 13,547,000USD | 11,348,000USD | 5,667,000USD | 8,982,000USD | 7,082,000USD |
| Other Non Cash Items | 1,000USD | -1,788,000USD | -2,023,000USD | 3,336,000USD | -3,099,000USD | -3,997,000USD | -5,059,000USD | -5,407,000USD |
| Change To Account Receivables | 936,000USD | 413,000USD | 2,204,000USD | -11,000USD | 2,470,000USD | -646,000USD | 1,347,000USD | -157,000USD |
| Change In Working Capital | 35,219,000USD | 65,479,000USD | -8,643,000USD | 7,204,000USD | -15,062,000USD | 2,456,000USD | -1,032,000USD | -8,013,000USD |
| Total Cash From Operating Activities | -113,976,000USD | -85,290,000USD | -94,003,000USD | -47,061,000USD | -52,331,000USD | -31,181,000USD | -21,962,000USD | -28,513,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -113,976,000USD | -85,290,000USD | -94,003,000USD | -47,061,000USD | -52,331,000USD | -31,181,000USD | -21,962,000USD | -28,513,000USD |
| Investments | 54,189,000USD | 75,612,000USD | 160,025,000USD | 42,506,000USD | 63,245,000USD | 6,584,000USD | 25,901,000USD | -126,059,000USD |
| Total Cashflows From Investing Activities | 54,189,000USD | 75,612,000USD | 160,025,000USD | 42,506,000USD | 63,245,000USD | 6,584,000USD | 25,901,000USD | -126,059,000USD |
| Total Cash From Financing Activities | 12,077,000USD | 75,103,000USD | 480,000USD | 507,000USD | 349,000USD | 1,000,000USD | 2,522,000USD | 2,905,000USD |
| Issuance Of Capital Stock | 11,627,000USD | 0USD | 0USD | 0USD | 0USD | -46,658,000USD | 46,658,000USD | -25,000USD |
| Change In Cash | -47,694,000USD | 65,434,000USD | 66,496,000USD | -4,060,000USD | 11,264,000USD | -23,671,000USD | 6,432,000USD | -151,664,000USD |
| Begin Period Cash Flow | 165,810,000USD | 100,376,000USD | 33,880,000USD | 37,940,000USD | 26,676,000USD | 50,347,000USD | 43,915,000USD | 195,579,000USD |
| End Period Cash Flow | 118,116,000USD | 165,810,000USD | 100,376,000USD | 33,880,000USD | 37,940,000USD | 26,676,000USD | 50,347,000USD | 43,915,000USD |
| Other Cashflows From Investing Activities | 125,690,000USD | — | -464,045,000USD | 165,993,000USD | 293,389,000USD | — | — | -126,059,000USD |
| Other Cashflows From Financing Activities | 11,627,000USD | 73,948,000USD | 480,000USD | 507,000USD | 349,000USD | 47,658,000USD | -44,136,000USD | 2,930,000USD |
| Unclassified Investing Cash Flow | -125,690,000USD | — | 464,045,000USD | -165,993,000USD | -293,389,000USD | — | — | 126,059,000USD |
| Unclassified Financing Cash Flow | -11,177,000USD | 1,155,000USD | — | — | — | — | 46,615,899USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | 42,101USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -359,639,000USD | -109,963,000USD | -85,895,000USD | -68,867,000USD | -54,990,000USD | -39,495,000USD | -25,779,000USD | -22,063,000USD |
| Depreciation | 431,000USD | 346,000USD | 292,000USD | 291,000USD | 296,000USD | 277,000USD | 260,000USD | 477,000USD |
| Stock Based Compensation | 40,818,000USD | 29,712,000USD | 16,750,000USD | 8,673,000USD | 6,100,000USD | 5,818,000USD | 3,743,000USD | 2,608,000USD |
| Other Non Cash Items | -9,273,000USD | -17,247,000USD | -8,071,000USD | 1,317,000USD | 3,935,000USD | 3,906,000USD | 807,000USD | -208,000USD |
| Change To Account Receivables | 5,076,000USD | 1,199,000USD | 321,000USD | 614,000USD | 1,176,000USD | 1,000USD | — | — |
| Change In Working Capital | 48,978,000USD | 9,362,000USD | 3,548,000USD | 10,189,000USD | -2,927,000USD | 7,717,000USD | -3,783,000USD | 823,000USD |
| Total Cash From Operating Activities | -278,685,000USD | -87,790,000USD | -73,376,000USD | -48,397,000USD | -47,586,000USD | -21,777,000USD | -24,752,000USD | -18,755,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -278,685,000USD | -87,790,000USD | -73,376,000USD | -48,397,000USD | -47,586,000USD | -21,777,000USD | -24,752,000USD | -18,755,000USD |
| Investments | 341,388,000USD | -553,366,000USD | -207,559,000USD | 54,753,000USD | 37,960,000USD | 41,567,000USD | 7,463,000USD | -265,729,000USD |
| Total Cashflows From Investing Activities | 341,388,000USD | -553,366,000USD | -179,086,000USD | 54,753,000USD | 37,960,000USD | 41,567,000USD | 7,463,000USD | -265,729,000USD |
| Total Cash From Financing Activities | 76,439,000USD | 612,464,000USD | 271,376,000USD | 4,163,000USD | 6,880,000USD | 950,000USD | 887,000USD | 300,275,000USD |
| Issuance Of Capital Stock | 0USD | 597,094,000USD | 269,760,000USD | — | — | — | 0USD | 296,607,000USD |
| Change In Cash | 139,134,000USD | -28,840,000USD | 18,884,000USD | 10,261,000USD | -2,746,000USD | 20,740,000USD | -16,402,000USD | 15,791,000USD |
| Begin Period Cash Flow | 26,676,000USD | 55,516,000USD | 36,632,000USD | 26,371,000USD | 29,117,000USD | 8,377,000USD | 24,779,000USD | 8,988,000USD |
| End Period Cash Flow | 165,810,000USD | 26,676,000USD | 55,516,000USD | 36,632,000USD | 26,371,000USD | 29,117,000USD | 8,377,000USD | 24,779,000USD |
| Other Cashflows From Investing Activities | -1,199,000USD | -1,199,000USD | — | 54,753USD | 37,960USD | 41,567USD | 7,463USD | -265,729USD |
| Other Cashflows From Financing Activities | 73,948,000USD | 15,370,000USD | 1,616,000USD | 10,958,000USD | -707,000USD | -296,000USD | -151,000USD | 7,501,000USD |
| Unclassified Financing Cash Flow | 2,491,000USD | 639,195,000USD | 276,881,000USD | — | 7,587,707USD | 1,246,296USD | 1,038,151USD | 296,607,127USD |
| Sale Purchase Of Stock | — | -42,101,000USD | -7,121,000USD | -6,795,000USD | -707USD | -296USD | -151USD | -127USD |
| Unclassified Investing Cash Flow | — | — | 28,473,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | 12,894,000USD | -3,050,000USD | 5,323,000USD | 3,866,000USD | 960,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 10,519,000USD | -2,746,000USD | 20,740,000USD | -16,402,000USD | 15,791,000USD |
| Net Borrowings | — | — | — | — | — | — | — | -3,833,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.